Empowering Tomorrow
Expanding Access to
Innovative Therapies
We have built a strong legacy of access by working closely with patients, launching dedicated support programs, and partnering with both provincial and federal health departments. Through these collaborative efforts, we have helped over 90,000 individuals receive life-saving treatments free of charge through industry-first access programs in collaboration with our global partners and the government
Key Programs and
Patient Impact
In collaboration with our Global partners, we have a legacy of access programs across Pakistan increasing access to innovative medicines targeting multiple therapy areas
- GIPAP (2003–2008): Supported 1,800 patients
- NOA (2008–2025): Supported over 8,843 patients
- SCM Sindh (2012–2021): Supported 4,000 patients
- SCM Punjab (2014–2024): Supported more than 7,000 patients
- SCM KP (2017–2023): Supported over 2,500 patients
- Federal (2018–2024): Supported 458 patients
- Novartis Access Program (2019–2025): Supported 70,000 patients across diabetes, hypertension, breast cancer, and respiratory illnesses
Commitment Beyond Medicines
Our commitment is about more than just bringing innovative medicines to Pakistan but also to build an ecosystem which makes them accessible to patients. We are dedicated to helping people live healthier, fuller lives, breaking down barriers to ensure that essential treatments are within reach for all
Social, Environmental &
Economic Impact – Pakistan
Social, Environmental, and Economic Impact measures how our activities and medicines create value — or incur costs — for society, the environment, and the economy across the full value chain
Our social impact includes:
- USD 74.9 million in total social impact generated from improved patient health
- 5.4 million patients reached across 50+ brands
- 17,850 QALYs (Quality-Adjusted Life Years) gained
- 3,800+ jobs supported across the country (including direct, indirect, and induced employment) This represents the improved health and life quality resulting from treatment.
Diversity, Equity &
Inclusion (DE&I)
We are deeply committed to maintaining Diversity, Equity & Inclusion (D,E&I) and are proud of our progress, all employment decisions are based solely on job-related factors — including skills, qualifications, and experience — without regard to sex/gender, race, ethnicity, or any other legally protected or personal characteristics unrelated to the role. We firmly uphold internal pay equity standards, ensuring nondiscrimination in compensation by paying employees fairly for similar roles based strictly on job-related factors. We also remain committed to pay transparency reporting
